[go: up one dir, main page]

MXPA02004069A - Uso de oxido nitrico para el tratamiento de construccion de vias aereas. - Google Patents

Uso de oxido nitrico para el tratamiento de construccion de vias aereas.

Info

Publication number
MXPA02004069A
MXPA02004069A MXPA02004069A MXPA02004069A MXPA02004069A MX PA02004069 A MXPA02004069 A MX PA02004069A MX PA02004069 A MXPA02004069 A MX PA02004069A MX PA02004069 A MXPA02004069 A MX PA02004069A MX PA02004069 A MXPA02004069 A MX PA02004069A
Authority
MX
Mexico
Prior art keywords
treatment
nitric oxide
airway constriction
constriction
airway
Prior art date
Application number
MXPA02004069A
Other languages
English (en)
Inventor
Josephine Hjoberg
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of MXPA02004069A publication Critical patent/MXPA02004069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02004069A 1999-11-03 2000-11-02 Uso de oxido nitrico para el tratamiento de construccion de vias aereas. MXPA02004069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (1)

Publication Number Publication Date
MXPA02004069A true MXPA02004069A (es) 2003-08-20

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004069A MXPA02004069A (es) 1999-11-03 2000-11-02 Uso de oxido nitrico para el tratamiento de construccion de vias aereas.

Country Status (20)

Country Link
EP (1) EP1225913B8 (es)
JP (1) JP2003513048A (es)
CN (1) CN1230199C (es)
AR (1) AR026335A1 (es)
AT (1) ATE302023T1 (es)
AU (1) AU778347B2 (es)
BR (1) BR0015329A (es)
CA (1) CA2389655A1 (es)
CZ (1) CZ20021559A3 (es)
DE (1) DE60022070T2 (es)
EE (1) EE200200240A (es)
ES (1) ES2248153T3 (es)
HU (1) HUP0203065A3 (es)
IL (1) IL149170A0 (es)
MX (1) MXPA02004069A (es)
NO (1) NO20022113L (es)
PL (1) PL354653A1 (es)
SE (1) SE9903985D0 (es)
WO (1) WO2001032202A1 (es)
ZA (1) ZA200203391B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
AU2003226603A1 (en) 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003279236B8 (en) * 2002-06-21 2009-02-19 Beth Israel Deaconess Medical Center, Inc. Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
KR20110094321A (ko) * 2008-12-03 2011-08-23 가부시키가이샤 엘티티 바이오파마 수식형 수퍼옥사이드 디스뮤타아제 함유 흡입제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122008000012I2 (de) * 1990-12-05 2012-04-12 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefassverengung und von Asthma.
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
EP1225913A1 (en) 2002-07-31
DE60022070T2 (de) 2006-03-30
EP1225913B8 (en) 2005-10-19
CN1230199C (zh) 2005-12-07
PL354653A1 (en) 2004-02-09
CZ20021559A3 (cs) 2003-05-14
HUP0203065A3 (en) 2006-07-28
CA2389655A1 (en) 2001-05-10
DE60022070D1 (de) 2005-09-22
HUP0203065A2 (hu) 2003-01-28
AR026335A1 (es) 2003-02-05
IL149170A0 (en) 2002-11-10
BR0015329A (pt) 2002-07-09
AU1745601A (en) 2001-05-14
EE200200240A (et) 2003-06-16
EP1225913B1 (en) 2005-08-17
NO20022113D0 (no) 2002-05-02
SE9903985D0 (sv) 1999-11-03
AU778347B2 (en) 2004-12-02
ATE302023T1 (de) 2005-09-15
JP2003513048A (ja) 2003-04-08
NO20022113L (no) 2002-05-02
WO2001032202A1 (en) 2001-05-10
ZA200203391B (en) 2002-12-20
CN1387441A (zh) 2002-12-25
ES2248153T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU8015600A (en) Respiratory nitric oxide meter
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
GB9915414D0 (en) Medical use
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
EP1207811A4 (en) STAIN OXIDE RELEASE MEDICAL ARTICLES
HUP0202150A3 (en) Use of nitric oxide donors for inducing neurogenesis
IL155968A0 (en) Inhalation of nitric oxide
GB0004531D0 (en) The treatment of respiratory diseases
MXPA03004303A (es) DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
AU2001293891A1 (en) New combination for the treatment of asthma
GB9907965D0 (en) Medical use
AU3593599A (en) Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
IL133760A0 (en) Composition for the treatment of dandruff
MXPA02004069A (es) Uso de oxido nitrico para el tratamiento de construccion de vias aereas.
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
AU8609201A (en) Reduction of the electrocardiographic ot interval
GB9925379D0 (en) Medical use
ZA200109120B (en) Use of Arylalkanoylpyridazines.
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
ZA991786B (en) Therapeutic treatment for asthma.
GB0212790D0 (en) Medicament for the treatment of diabetes
AP2004003014A0 (en) Use of specific dose of fondaparinux sodium for the treatment of ACS.

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights